Clinical impact and cost-effectiveness of vaccinating infants and adolescents against invasive meningococcal B disease in the Netherlands

Thomas Otten, Mirjam Knol, Lard Montesano Montessori, Pieter de Boer, Anneke Steens

Open source

DOI
10.1186/s12916-026-04651-z
Published
2026-02-10
Container
BMC Medicine
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s12916-026-04651-z,
  title = {Clinical impact and cost-effectiveness of vaccinating infants and adolescents against invasive meningococcal B disease in the Netherlands},
  author = {Thomas Otten and Mirjam Knol and Lard Montesano Montessori and Pieter de Boer and Anneke Steens},
  year = {2026},
  journal = {BMC Medicine},
  doi = {10.1186/s12916-026-04651-z},
  url = {https://doi.org/10.1186/s12916-026-04651-z}
}

RIS

TY  - JOUR
TI  - Clinical impact and cost-effectiveness of vaccinating infants and adolescents against invasive meningococcal B disease in the Netherlands
AU  - Thomas Otten
AU  - Mirjam Knol
AU  - Lard Montesano Montessori
AU  - Pieter de Boer
AU  - Anneke Steens
PY  - 2026
JO  - BMC Medicine
DO  - 10.1186/s12916-026-04651-z
UR  - https://doi.org/10.1186/s12916-026-04651-z
ER  - 

APA

Otten, T., Knol, M., Montessori, L. M., Boer, P. D., & Steens, A. (2026). Clinical impact and cost-effectiveness of vaccinating infants and adolescents against invasive meningococcal B disease in the Netherlands. BMC Medicine. https://doi.org/10.1186/s12916-026-04651-z

Source records